Activated STAT regulates growth and induces competitive interactions independently of Myc, Yorkie, Wingless and

Aloma B Rodrigues1, Tamara Zoranovic, Aidee Ayala-Camargo

  • 1Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.

Development (Cambridge, England)
|September 21, 2012
PubMed

Insights

Cell competition regulates organ size and involves cancer-like processes. Modulating STAT activity levels determines cell survival, with low STAT leading to cell death and high STAT promoting cell killing.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cell competition is a conserved mechanism for tissue homeostasis and organ size control.
  • It shares similarities with early stages of cancer development.
  • In Drosophila, supercompetitor cells (e.g., with high Myc) eliminate neighboring 'loser' cells.

Purpose of the Study:

  • To investigate the role of STAT (Signal Transducer and Activator of Transcription) activity in cell competition.
  • To determine how STAT signaling influences the survival or elimination of competing cells.

Main Methods:

  • Utilized Drosophila melanogaster as a model organism.
  • Manipulated STAT activity levels in wing cells.
  • Assessed cell survival and elimination based on STAT activity and other signaling pathways (Myc, Wingless, Yorkie, hid).

Main Results:

  • Cells lacking STAT activity become 'losers' and are eliminated by wild-type neighbors.
  • Hyper-activated STAT cells act as 'supercompetitors', killing distant loser cells.
  • STAT-mediated killing is dependent on 'hid' but independent of Myc, Yorkie, Wingless, and ribosome biogenesis.

Conclusions:

  • STAT signaling is a major parallel regulator of cell competition, alongside Wingless and Myc.
  • These pathways may converge on non-autonomous signals that eliminate loser cells.
  • Findings have implications for cancer therapy and regenerative medicine due to STAT's role in tumorigenesis and stem cell niches.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...